Interleukin enhancer‐binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma
Zhang, Xiaoqing, Bustos, Matias A., Gross, Rebecca, Ramos, Romela Irene, Takeshima, Teh‐Ling, Mills, Gordon B., Yu, Qiang, Hoon, Dave S. B.
Published in Clinical and translational medicine (01.10.2021)
Published in Clinical and translational medicine (01.10.2021)
Get full text
Journal Article
AIM1 and LINE-1 Epigenetic Aberrations in Tumor and Serum Relate to Melanoma Progression and Disease Outcome
Hoshimoto, Sojun, Kuo, Christine T., Chong, Kelly K., Takeshima, Teh-Ling, Takei, Yoshiki, Li, Michelle W., Huang, Sharon K., Sim, Myung-Shin, Morton, Donald L., Hoon, Dave S.B.
Published in Journal of investigative dermatology (01.06.2012)
Published in Journal of investigative dermatology (01.06.2012)
Get full text
Journal Article
Acetylated DNMT1 Downregulation and Related Regulatory Factors Influence Metastatic Melanoma Patients Survival
Zhang, Xiaoqing, Bustos, Matias A, Shoji, Yoshiaki, Ramos, Romela Irene, Iida, Yuuki, Gentry, Rebecca, Takeshima, Teh-Ling, Hoon, Dave S B
Published in Cancers (18.09.2021)
Published in Cancers (18.09.2021)
Get full text
Journal Article
Predictive Utility of Circulating Methylated DNA in Serum of Melanoma Patients Receiving Biochemotherapy
MORI, Takuji, O'DAY, Steven J, VU, Vu D, NGUYEN, Sandy L, HOON, Dave S. B, UMETANI, Naoyuki, MARTINEZ, Steve R, KITAGO, Minoru, KOYANAGI, Kazuo, KUO, Christine, TAKESHIMA, Teh-Ling, MILFORD, Robert, WANG, He-Jing
Published in Journal of clinical oncology (20.12.2005)
Published in Journal of clinical oncology (20.12.2005)
Get full text
Journal Article
Conference Proceeding
Abstract 3233: Interleukin enhancer-binding factor 2 amplification controls mRNA stability and enhances DNA damage response in metastatic melanoma
Zhang, Xiaoqing, Bustos, Matias A., Gross, Rebecca, Ramos, Romela Irene, Takeshima, Teh-Ling, Mills, Gordon B., Yu, Qiang, Hoon, Dave S.
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article